Fortress Biotech Inc.

07/31/2020 | Press release | Distributed by Public on 07/31/2020 05:34

Fortress Biotech Announces Positive Opinion on Orphan Drug Designation Received from the European Medicines Agency for CUTX-101, Copper Histidinate, for the Treatment of Menkes[...]